Background Every year, 1·1 million babies die from prematurity, and many survivors are disabled. Worldwide, 15 million babies are born preterm (<37 weeks' gestation), with two decades of increasing rates in almost all countries with reliable data. The understanding of drivers and potential benefi t of preventive interventions for preterm births is poor. We examined trends and estimate the potential reduction in preterm births for countries with very high human development index (VHHDI) if present evidence-based interventions were widely implemented. This analysis is to inform a rate reduction target for Born Too Soon.
Introduction
Every year, about 1·1 million neonates die from complications of preterm birth as estimated in 2010. 1 Preterm birth is now worldwide the second most common causeof-death in children younger than 5 years after pneu monia, and is decreasing at a much slower rate than pneumonia, even increasing in several countries. Add itionally, preterm birth is the leading risk factor for 393 000 deaths due to neonatal infections and contributes to long-term growth impairment and substantial long-term morbidity such as cognitive, visual, and learning impairments. 2, 3 The fi rst-ever national estimates of preterm birth (defi ned as <37 completed weeks of gestation) were recently published in The Lancet, 4 undertaken with the WHO, and included a country clearance process in which all UN member states countries were invited to review their estimates and provide feedback. These estimates showed a total of 15 million babies born preterm in 2010, 5% of which were under 28 weeks' gesta tion.
from preconception, through pregnancy, birth, and for newborn care. 5 Reduction in preterm mortality in highincome countries has been largely due to improved care and policy changes, and this care has yet to be scaled up in most low-income and middle-income countries. 5 Born Too Soon set a goal of 50% reduction of preterm specifi c mortality by 2025, which was based on historical reductions in the USA and UK, rates of reduction of preterm-specifi c deaths in well performing low-income and middle-income countries, and an analysis of lives saved with very feasible interventions such as kangaroo mother care and antenatal steroids. The report was a joint eff ort involving 50 organisations, it has a Foreword by the UN Secretary-General, and contains new commitments by 31 organisations linked to the accountability framework of the Every Woman Every Child movement. 5 The survival gap for preterm babies is mainly an action gap for intervention implementation low-income and middle-income countries. However, the the worldwide epidemic of preterm birth aff ects low-income, middleincome, and high-income countries alike, and the gap for preterm prevention is mainly a knowledge gap. Our understanding of the underlying drivers for preterm birth or the potential eff ect of preventive interventions remains poor, although recent advances in classifi cation of the preterm birth syndrome provide helpful advances. Born Too Soon therefore recommended that "a technical expert group will be created to consider a goal for reduction of preterm birth rate by 2025 for announcement on World Prematurity Day 2012." 5, 6 Thus, our aim was to do a multicountry analysis of the trends in preterm birth rates for 2000-10 in countries with more robust data, and to estimate the potential reduction in preterm birth with full imple mentation of currently proven interventions. A sec ondary objective was to consider the setting of a preterm birth reduction target for these countries.
Methods

Assessment of national data and time trends for preterm birth rates
Recent national estimates 4 of preterm births were based on 738 reported data inputs from 99 countries, from 1990 to 2010. This analysis identifi ed a paucity of consistent reliable data for countries in regions without robust registration systems. Hence, a statistical model was used to estimate preterm birth rates in 2010 for 184 countries with more than 10 000 livebirths, but it was unable to estimate time trends in low-income and most middle-income countries. Most input data (547 of 738) were from the 65 countries in the Developed, Latin America, and the Caribbean MDG regions. Hence the 1990-2010 time trend analysis was focused on these countries with use of country-level Loess regression to smooth reported data for the 12 countries with adequate data during the 21-year period and statistical modelling with own and regional data for the other 53 countries. 4 Loess regression is a locally weighted regression method, it was used to fi t a smooth curve to the country-specifi c preterm data using a weighted least squares method to Step 1
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Figure 1: Country selection process for preterm birth rate trends analyses n=number of countries. (A) Inclusion criteria for countries with reliable preterm birth trend data. (B) Examination of "high-income" country groupings with best fi t for countries with high-quality preterm birth data. Data of preterm prevalence from Blencowe H and colleagues. 4 For country groupings see appendix (pp 1-2).
minimise year on year fl uctuations. This method makes use of the data available from the specifi c country to provide estimates for every year, giving more weight to the datapoints nearest to the year estimating for.
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Inclusion criteria and regional grouping
We assessed the data from these 65 countries with a focus on the 2000-10 period. High-quality data were available for 28 countries for that period (fi gure 1A). We excluded countries with fewer than 10 000 livebirths in 2010 from all defi nitions of high-income countries in accordance with the method ology used in the previous time trends analyses by Blencowe and colleagues 4 (appendix pp 1-2). To identify the most appropriate regional grouping with a high proportion of the countries having good quality data, we examined various defi nitions of high-income or developed countries to identify which grouping contained the highest share of these countries with high-quality data availability. We considered the following four options: World Bank "high-income economies", UN Development Programme "Very High Human Development Index" (VHHDI), UN Statistics Division "developed region", and the MDG "developed region". The 26 countries with highquality data constituted 67% of the 39 UN Development Programme VHHDI countries with more than 10 000 livebirths per year, the highest of the four options examined (fi gure 1B). Of these 47 countries with VHHDI, 39 had more than 10 000 livebirths per year and were included in our analysis (appendix p 2). 26 of these countries had high-quality reported or Loess data (6% of global preterm births from 2010) and for the remaining 13 countries, we used their own data with modelled adjustment from Blencowe and colleagues 4 (2% of global births in 2010; fi gure 2, appendix pp 3-4).
To estimate the potential eff ect of preventive interventions for these 39 countries with VHHDI, we used the 2010 preterm birth rates as the baseline, pre-intervention preterm birth rate (appendix p 5). We analysed the average annual rate of change (AARC) of preterm birth rate for diff erent time periods, including only countries with VHHDI with high-quality data for pre term birth rates spanning at least 5 of the 6 years for every time period (eg, 2000-05, 2005-10; appendix p 6). This exclusion was to minimise the eff ect of year-to-year fl uctuations on the AARC and helped to more accurately represent the overall trend. 23 of the 39 countries with VHHDI had enough data for estimating the AARC for both 2000-05 and 2005-10 time periods.
We did a projection of potential reduction in preterm births to estimate the reduction in countries with VHHDI if all countries achieved the same as those with the greatest reduction in preterm birth rates for three diff erent Data of preterm prevalence data availability from Blencowe H and colleagues. 4 Some countries with high-quality data only had data for subnational populations (eg, UK and Belgium). 
Analysis of drivers for rise in preterm birth in USA
We analysed the rise in preterm births in the USA. We selected the USA because of its high preterm birth rate (double most European countries), its rising rates then recent reductions suggesting a changing pattern, and its data availability for rates and drivers, but this analysis was not applied to other countries. We identifi ed po tential drivers that might have contributed to the rising rate of preterm births in the USA between 1989 and 2004 on the basis of scientifi c literature and discussions with the Born Too Soon preterm prevention analysis group. 8 To estimate the contributions from every driver, we took the following approach: (1) identify the distri bution of mothers aff ected (eg, maternal age), (2) identify the risk of preterm birth for every category (eg, by maternal age), and (3) calculate the total contribution to the diff erence in preterm birth rate between 1989 and 2004 for every driver. Importantly, we avoided overlap of contributions from diff erent drivers in the analysis by using preterm birth odds ratios (ORs) from logistical regression modelling that simultaneously controlled for all except the variable of interest using individualised data (eg, maternal age is associated with increased use of assisted reproductive technologies). 8, 9 We calculated the contribution to the diff erence in preterm birth rate between 1989 and 2004 for every age group by multiplying the percentage of mothers in every age group with the corresponding OR and subtracting the result for 1989 from 2004. Details on specifi c data sources and methodology are presented in the appendix (pp 8-14). 8, [10] [11] [12] [13] [14] Estimation of the eff ect of interventions to reduce preterm birth
We used the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) Review Group report 15 to identify a list of preventive interventions for consideration. The GAPPS team systematically assessed about 2000 intervention studies published up until Dec 31, 2008 , and applied an adaptation of the Grades of Recommendation Assessment, Development, and Evaluation (GRADE) criteria. 15 Three preventive interventions had a high level of evidence (smoking cessation, progesterone, and zinc supple men tation), but only two (smoking cessation and proges terone) were strongly recommended for implementation for preterm birth prevention and were included in our analysis (table) .
For the 18 interventions in the GAPPS review 15 with "very low," "low", and "moderate" evidence of effi cacy, or "high" level of evidence for no eff ect, we searched for new evidence published since 2008 that might change these assessments (appendix p 15). We focused on high-quality reviews such as Cochrane, and identifi ed new reports for seven interventions (cervical cerclage, micro nutrient supple mentation, protein energy supplemen tation, iron and folate supplementation, magnesium sulphate supplementation, screening and treatment of asympto matic bacteriuria, and multivitamins for HIV-positive women). Of these, only cervical cerclage had a notable change in evidence for effi cacy on prevention of preterm births. 16, 17 New evidence showed that "in women with previous spontaneous preterm birth, singleton gestation, and cervical length less than 25 mm, cervical cerclage signifi cantly prevents pre term birth and com posite perinatal mortality and morbidity." 15, 16 Thus, we included cervical cerclage in our analysis. The GAPPS review 15 focused on interventions relevant to the low-income and middleincome countries so we also in cluded two interventions of relevance to high-income countries, notably decrease of non-medically indicated caesarean delivery and labour induction and limiting multiple-embryo transfer in assisted reproductive technologies.
For the analysis on decreasing multiple births from assisted reproductive technologies, we used the European average for countries without available reported 15 New evidence supporting effi cacy of cerclage from Berghella and colleagues Obstetrics and Gynecology 2011. 16 GRADE=grading of recommendations assessment, development, and evaluation. HIC=high-income countries. MIC=middle-income countries. LIC=low-income countries. NA=not applicable. Appendix (pp 16-17) for eff ect estimate applied for each intervention and appendix (p 15) for other interventions that were considered but excluded from analysis.
Table:
Interventions meeting selection criteria for analysis of prevention of preterm birth data for total livebirths with assisted reproductive technologies, present rate of multiple births from these technologies, and preterm birth rate associated with each plurality in these technologies. 18 We assumed the target plurality distribution for births with assisted reproductive technologies to be singleton : twins : triplet = 89·5% : 10·0% : 0·5% on the basis of expert opinion about plurality distribution if most live births these technologies resulted from single embryo transfer.
We did country-by-country analyses of the potential reduction in preterm birth rates for the fi ve included interventions. The general approach was: (1) identify and size of the target population for the intervention, (2) estimate the incremental coverage for the intervention to reach full coverage of the target population, (3) estimate the expected effi cacy for the intervention, and fi nally (4) obtain the estimated impact in reduction of preterm birth rate and preterm births averted (population attributable risk) and combine this for the 39 countries with VHHDI weighted by the country's number of preterm births for 2010. Effi cacy for every intervention was based on scientifi c literature applying the following hierarchy: Cochrane Review, meta-analysis, randomised controlled trials, and other studies. The data used and specifi c method ology for every analysis can be found in the appendix (pp 16-31). 8, 10, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] For assisted reproductive technologies, effi cacy of the intervention was estimated as the diff erence between the existing rate of preterm births among livebirths associated with assisted repro ductive technologies of each plurality (ie, twins and triplets) and that of an ideal plurality distribution (appendix p 17). This so-called ideal plurality distribution among livebirths associated with assisted reproductive tech nologies was set as a rounded average of performance in countries with VHHDI already with very low multiple births from assisted reproductive technologies (ie, Sweden) and the current European average. 18 For cae sarean delivery and labour induction, we assumed a goal of 80% combined elimination for the analysis. This is an optimistic but not unrealistic goal, as experiences in the USA have shown that more than 80% reduction (25% to <5%) in elective delivery between 36 (0/7)-38 (6/7) weeks without a documented medical indication is possible within 2 years. 31 Coverage data were sourced from national health databases and statistical offi ces.
Estimation of potential cost savings
We calculated the economic cost savings associated with reduction in preterm birth rate using the projected number of preterm births averted for every country and the incremental cost associated with every preterm birth. It has been estimated that the total economic cost, including the costs of medical care services, early intervention services, special education services, and lost household and labour market productivity was US$51 600 per preterm birth in the USA in 2005. 32 Other more sensitive cost analysis using gestation-specifi c additional costs would be preferred but were not possible because of not enough data by country and on the same gestation specifi c banding. 33 Using purchasing power parity conversion factor from the World Bank, we obtained the estimated incremental cost of preterm birth in the local currency of every VHHDI country (appendix pp [32] [33] [34] [35] . Then, we converted the cost for every country into US$ using currency exchange rates from the World Bank and Organization for Economic Co-operation and Develop ment (OECD; appendix pp 32-33).
Role of the funding source
The sponsoring agencies fi nancial management had no role in study design, data collection, data analysis, data interpretation, or writing of the report. HHC, JL, HB, and JEL had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
The estimated 2010 preterm birth rates varied between countries with VHHDI, from 5·3 per 100 livebirths in Latvia to 14·7 per 100 livebirths in Cyprus (fi gure 3). National trends in preterm birth rates are a poor predictor of future trends in many of the 39 countries (appendix p 36). We estimated the 2015 preterm birth rate for every country assuming each followed its historic AARC for 2000-10 and 2005-10, or alternatively, as being stable since 2010 (appendix pp [37] [38] . No consistent pattern was identifi able. In some countries the stable assumption will yield the highest projection, whereas in others the lowest. These two fi ndings (levelling of trends 2005-10 and inconsistent projections based on historic data) suggest that modelling future preterm birth rates with a fl at baseline as the counterfactual is an appropriate and conservative approach.
To estimate potential reduction of preterm birth rates if all countries achieved the same progress as that of the best performing countries, we projected the average preterm birth rate for all countries with VHHDI for 2010-15 assuming they all reduced their preterm birth rate as fast as the average of the two best performers for various time periods the projection resulted in roughly 5% relative reduction in preterm birth rate by 2015, similar to the relative reduction of about 5% in our intervention analysis (fi gure 4). The preterm birth rate in the USA increased from 10·6% to 12·5% between 1989 and 2004. 11 We estimated the contribution to the increase in preterm birth rate during this time from seven diff erent drivers (fi gure 5; appendix pp 8-14).
8,10-14 For example, mothers in 2004 were older than in 1989, with a simultaneous increase in mothers older than 40 years and decrease of those younger than 19 years. The ORs for preterm birth (adjusted for all other variables) were highest for the oldest and youngest mothers, at 1·7 times (oldest) and 1·6 (youngest) times that of control (age 20-24 years). 8 Only about 50% (0·91%/1·90%) of the change in preterm birth rate between 1989 and 2004 can be explained by the seven drivers, with non-indicated cesarean delivery and labour induction together accounting for about 20% (0·4/1·90%) of the change (fi gure 5). This analysis shows the contribution of these drivers to the change, rather than contribution to the absolute preterm birth rate, which would require a more comprehensive understanding of the pathogenesis of preterm birth than is presently available.
We estimated the potential eff ect of existing interventions in lowering preterm birth rates in the countries with VHHDI. We focused on fi ve interventions meeting inclusion criteria: smoking cessation, progesterone, cervical cerclage, decreasing non-medically indicated labour or caesarean delivery induction, and decreasing multiple births from assisted reproductive technologies (table) . 8, 10, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] Combining the size of the target popu lation, incremental increase in coverage, and effi cacy of interventions, we obtained estimates for potential reduction in preterm birth rate for each intervention (appendix pp [16] [17] .
In 39 countries with VHHDI, by applying these fi ve selected interventions preterm birth rates can have a relative reduction of an estimated 5%, corresponding to change in absolute preterm birth rate from 9·6% to 9·1% (fi gure 6, appendix pp 39-40). Reduction of nonmedically indicated caesarean delivery and induction of labour has the largest eff ect, accounting for roughly half of the impact. However, signifi cant variability exists across countries in the absolute impact (about 1% to roughly 8% relative reduction), but also the relative contribution of individual interventions that is variable across countries (appendix pp 41-60). For example, whereas reduction of non-indicated caesarean delivery and labour induction has the highest impact in the USA, it would make a negligible diff erence in Sweden (fi gure 6B, C). By contrast, cervical cerclage for women with previous preterm birth and short cervix is estimated to have most impact in Sweden (fi gure 6C).
If 5% relative reduction is achieved by the included countries, about 58 000 preterm births can be averted annually (appendix pp 61-62), amounting to roughly US$3·0 billion in total economic cost savings (appendix p [32] [33] [34] [35] . This projected cost savings is signifi cant but still leaves a major cost and burden, highlighting the need for novel preventive interventions against preterm birth with greater impact. 
Discussion
Although preterm birth is the leading cause of death for children younger than 5 years in high-income countries, second leading cause worldwide, and a major contributor to the Global Burden of Disease, this is the fi rst multicountry analysis of trends in preterm birth rates and the potential for prevention through existing interventions (panel). Shockingly, very little reduction is currently possible. Even with assumed optimum coverage of these interventions in countries with VHHDI, the potential reduction in preterm birth rate is tiny, with about 58 000 preterm births averted across 39 countries, but the associated US$3 billion total economic cost savings is impressive given the complexity of care provided in USA for very preterm babies. These analyses were limited to the countries with VHHDI because of the scarcity of time trend data in low-income countries, even though rates of preterm births are generally higher in low-income countries. Additionally, several of the interventions we modelled are not relevant for low-income settings-ie, in rural west Africa, the caesarean delivery rate is almost zero, so excess caesarean deliveries are not the issue. Furthermore, some interventions such as cervical cerclage would not be feasible in such settings.
On the basis of these analyses, we propose a target of 5% relative reduction by 2015 on average across the countries with VHHDI. There were two motivations for proposing a near-future target of 2015 as compared with a later date. First, this date is feasible, because in the top-performing countries with VHHDI, AARC in preterm birth translates to about 5% relative reduction in 5 years (fi gure 4). Second, our hope is that this target will motivate immediate action in the countries with VHHDI, while more eff ective preventive interventions are being developed. This target is a weighted average for 39 countries, and some countries might achieve greater or smaller reductions. For example, our inter vention analysis shows that an 8% relative reduction in preterm birth rate is possible in the USA, but only 2% probable in Sweden (fi gure 6B, C). Coincidentally, our USA result is remarkably consistent with the rate reduction target of 8% in the USA by 2014 put forth by the Association of State and Territorial Health Offi cials (ASTHO) and the March of Dimes, with pledges to date from 48 of the 50 states in the USA. We have provided the analytical underpinning of the proposed 5% relative rate reduction target. Although previous targets have been set (eg, UNICEF Child Survival reduction of low birthweight goal set in 1990, US Healthy People 2020 preterm birth reduction goal, ASTHO), the quantitative basis for those goals are not in the public domain. While the setting of policy goals requires political traction, the transparent assessments of evidence and feasibility are crucial to consider as well, and we believe should be peer reviewed and published.
Half of the increased preterm birth rate in USA between 1989 and 2004 is unexplained by this analysis, which is an important constraint in any analyses of preterm birth rates, and a widely-recognised, funda mental knowledge gap when observing increased spontaneous preterm birth and has implications for prevention. The fi ndings from the USA might not be generalisable for other periods or to other countries, and we have not attempted to do so. Our analysis was constrained by the availability of likelihood ratios for preterm births that simultaneously adjusted for all other variables. 8, 34 When estimating the impact of existing interventions on preterm birth prevention we were able to include only fi ve interventions. Other interventions may have an eff ect but could not be included because of insuffi cient data. Teenage pregnancy, for example, is relevant for economies of high, low, and middle income, but age-related preterm birth intervention data are missing. Other maternal chronic disorders such as hyper tensive disease of pregnancy, diabetes, and obesity associated with preterm birth are important contributors, but we were unable to estimate the eff ect of interventions on their contributing factors because of insuffi cient data regarding pretermspecifi c eff ect. [35] [36] [37] [38] Interventions such as birth spacing and treatment of maternal infections (eg, syphilis, HIV/AIDS) are important interventions, especially in sub-Saharan Africa where preterm rates are highest, but again no or very few studies have assessed the eff ect on preterm births. 5, 15 Newer studies suggest cervical pessary for women with short cervix might be a promising option awaiting more trials. [39] [40] [41] [42] These should all be areas of focus for future studies.
Importantly, although reduction of preterm birth focuses on stopping non-indicated preterm births, in some situations, such as eclampsia, preterm birth is defi nitely indicated and is the only possible outcome for a live mother or baby or both. Thus, the goal of 0% preterm birth cannot be achieved unless preventive therapies are identifi ed that eliminate all maternal, fetal, and obstetrical complications. Some of the increase in preterm birth is due to improved and totally appropriate obstetric management of poor fetal growth and the tradeoff between stillbirth risk and yet minimising preterm birth risk is well recognised. 43 These results provide estimates for the potential eff ect of interventions, but do not off er guidance on individual clinical decision making. Additionally, despite their potential eff ect in reduction of preterm births, interventions such as progesterone supplementation and cerclage might have potential risks associated with delayed labour that re quire further elucidation and must be tracked, such as later neuropsychological impairment. 44 Our analysis of the preterm birth time trends and modelling of the baseline was constrained by the limited availability of trend data for preterm birth rates at national level. We had to rely on reported or Loess regression-fi tted data. 4 Although 60% (14 of 23 with suffi cient time trend data) countries with VHHDI have a stable or decreasing preterm birth rate between 2005 and 2010, the remaining 40% are still rising. If this trend were to reverse, and the preterm birth rates in countries with VHHDI rise again, then the estimated net change in preterm births from the 2010 baseline due to the preventive interventions would be even smaller. This is a real possibility given the absence of correlation between historical and future changes in preterm birth rates.
Panel: Research in context
Systematic review An estimated 15 million babies are born too soon every year, with preterm birth the largest cause of neonatal death worldwide and second leading cause of deaths in children younger than 5 years. In the past two decades, preterm births have increased in all countries with reliable data. However, understanding of the drivers of preterm birth and the most eff ective interventions to reduce preterm birth rates is poor. We used impact data from systematic reviews, assessing quality of evidence using GRADE, and coverage of interventions obtained from databases in the 39 countries including national health databases and statistical offi ces. Our analysis for 39 countries with VHHDI examines more recent trends, drivers of preterm birth rate increases in the USA, and estimates the eff ect of interventions on preterm birth prevalence, including impact data from systematic reviews, and coverage of interventions obtained through database searches including national health databases and statistical offi ces.
Interpretation
To our knowledge, this is the fi rst analysis to estimate the potential reduction in preterm births across high-income countries through preventive interventions. Our detailed analysis for the most recent decade suggests a levelling off of the previous almost universal increasing rate in high-income countries. However, analysis of previous increases in one country (USA) show that about half of the increase cannot be accounted for. Our new analysis of the eff ect of full coverage of fairly complex, available interventions, suggests that the scope for reducing preterm birth in these countries is estimated to be small (<5% relative reduction). This analysis highlights the need for the development of new and more eff ective interventions for preterm births.
Target population and coverage data also posed challenges. These interventions might overlap in their target population, resulting in an overestimation of their eff ect. We tried to avoid this overestimation by carefully defi ning the target population for every intervention. For example, effi cacy of cervical cerclage was estimated for women with previous preterm birth with short cervix, and that for progesterone was estimated for women with previous preterm birth but without short cervix. 45 With respect to smoking cessation, only 25 of the 39 included countries had data available of the percent of pregnant women smoking (appendix p 25) and we applied the mean from European countries. We assumed that the OR of preterm birth in mothers who smoked was biological in origin and could be modelled as a global-specifi c rather than country-specifi c risk. 26 The reported effi cacy of smoking cessation programmes varies greatly depending on the study. 22, 28 We identifi ed a single meta-analysis 19 of eight randomised trials that directly reported the effi cacy of smoking ces sation programmes for pregnant women, which was used for all countries in the analysis and is an obvious simplifi cation in view of probable diff erences in effi cacy of such behavioural interventions across countries. 19, 46 For cervical cerclage, we defi ned the target population as women with previous preterm birth and with short cervix, since data of the effi cacy of cervical cerclage were only available for this population. 17 However, we were only able to identify published data about the present usage of cervical cerclage in all mothers, rather than our defi ned target population for the USA. 20 We therefore applied the assumption that the use of cervical cerclage was within our target population of women with short cervix and previous preterm birth, which is likely an overestimate, making our analysis conservative. No data of coverage of cervical cerclage were available for countries outside the USA; therefore this estimate was applied to all the included countries with VHHDI, which might diff er substantially in obstetric practices.
We used the estimated potential effi cacy of progesterone from the recent systematic review. 47 We assumed the target population for proges terone use to be only women with a singleton gestation with previous preterm birth without short cervix. 45, 48 This assumption was to avoid overlap of target population with that for cervical cerclage and thus indicates the incremental eff ect in the population of progesterone on top of cervical cerclage. We were unable to identify national coverage data for progesterone use in countries with VHHDI. In view of this, we assumed that two-thirds of the indicated population has access to proges terone as the maximum possible existing coverage after consultations with experts. This might be an overestimate and would surely vary by country. We expect the potential eff ect of progesterone to be greater if true present coverage is lower than what we estimated, making our estimate conservative.
With respect to elective caesarean deliveries and induc tions without medical indication, the frequency of non-medically indicated labour induction and caesarean delivery is notoriously diffi cult to estimate. 49 We assumed that only late preterm births could potentially be non-medically indicated and that all moderate or early preterm births delivered through labour induction or caesarean deliveries were medically indicated. Analysis in Canada suggests that the issue is more through induction than caesarean delivery. 50 We applied one published result for the USA from 2002-08, and scaled it to the rest of the world using reported countryspecifi c elective caesarean delivery rates (appendix p 28). 21, 24 In view of the recent push to reduce incidence of late preterm births from labour induction or caesarean deliveries, this might be an overestimate. However, in the absence of other data, we chose to use this one result rather than make any new assumptions. Finally, for the purpose of this analysis, we assumed that 80% of the non-medically indicated labour induction and caesarean deliveries could be reduced in our target population. We recognise that this will vary from country to country.
For the analysis on decreasing multiple births from assisted reproductive technologies, the target plurality distribution for births with assisted reproductive technologies that we assumed is more stringent than many existing guidelines for assisted reproductive technologies 29 but for most European countries, the existing plurality distribution among assisted repro ductive technologies births is already at or better than our target rate, limiting the potential eff ect of this intervention. 10, 18 In some countries, the target rate might be diffi cult to achieve in view of current health-care reimbursement schemes for such technologies that may exclude ART; thus, patients must pay out of pocket and may be insistent on other than single embryo transfer. We also assumed that the rate of livebirths associated with assisted reproductive technologies would remain the same, which might diff er from actual outcome. 51 To estimate the total economic cost savings associated with reduction in preterm birth rate, we used the incremental cost associated with the care of an additional preterm birth from the USA Institute of Medicine (IOM) report 32 and extrapolated to the rest of the countries with VHHDI, applying the purchasing power conversion in this extrapolation. The IOM report might substantially understate the cost of preterm birth. A high-quality study 33 for England and Wales estimated the average cost of a preterm birth to be about $35 471. This cost is almost 40% more than the roughly $25 688 we estimated for the UK using the US estimates from IOM and scaling based on purchasing power parity, suggesting that our $3 billion estimate of total cost might be substantially understated. We were unable to identify similar cost estimates for all countries with VHHDI, but recognise that there is a growing body of work on this topic, and a more detailed country-by-country analysis would be valuable taking into account the gestational spectrum, which has been shown to substantially aff ect costs. 33 Although the present analysis focuses on the countries with VHHDI, applicability of these selected interventions extends beyond these countries. For example, the prevalence of caesarean deliveries in some middleincome countries is extremely high (eg, 46% for Brazil, 38% for Mexico, and 26% for China); thus, the reduction of non-medically indicated caesarean deliveries could potentially have a large impact on reduction of preterm birth rate. 21 Smoking in young women continues to rise in many emerging economies and cessation programmes might have a larger eff ect in these societies. There are other preventive interventions, ranging from birth spacing to treating maternal infection, notably malaria, HIV, and syphillis, or improving nutrition, which are highly relevant for low-income and middleincome countries. These were not included in our present analysis because they did not have suffi ciently robust preterm-specifi c impact data for in clusion and were less applicable to the countries with VHHDI.
By the year 2025, countries that take action now could potentially halve their deaths due to preterm birthsa very large potential reduction on the mortality side, driven by current low coverage of care in low-income and middle-income countries. 5 However, on the prevention side, by 2015 at best we can reduce the preterm rates by only 5% in the richest countries if all countries can match the rate of relative reduction in preterm births among the top-performing countries and if these rather challenging existing interventions can be scaled up. Surely this humbling and shocking fi nding must lead to strategic prioritisation of research into prevention of preterm births in countries with VHHDI. The path ahead includes improved appropriate classifi cation for the causes of preterm birth, allowing for better diagnosis and risk stratifi cation, followed by develop ment of novel prevention interventions based on better understanding of the underlying aetiologic, intergen erational, and genetics studies. [52] [53] [54] We hope that these new interventions, once developed, will also be rapidly translated from high-income countries to the rest of the world where the burden of preterm birth is even higher.
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